Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Prometheus Biosciences, Inc. - Common Stock
(NQ:
RXDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prometheus Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
↗
April 18, 2023
Shares of its takeover candidate nearly doubled on the news.
Via
Investor's Business Daily
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry
April 18, 2023
EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END
Via
FinancialNewsMedia
Expert Ratings for Prometheus Biosciences
↗
April 17, 2023
Via
Benzinga
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
↗
April 17, 2023
U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24% to 12,093.82. The S&P 500, also fell, dropping, 0.17% to 4,130.78.
Via
Benzinga
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
↗
April 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 17, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 17, 2023
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.
Via
Benzinga
Why Shares of Prometheus Biosciences Are Soaring Monday
↗
April 17, 2023
Merck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher.
Via
The Motley Fool
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
↗
April 17, 2023
U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,890.03 while the NASDAQ fell 0.18% to 12,101.34. The S&P 500, also fell,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
↗
April 17, 2023
Via
Benzinga
US Stocks Mostly Flat; NY Empire State Manufacturing Index Surges In April
↗
April 17, 2023
U.S. stocks traded mostly flat this morning, following the release of economic data. Following the market opening Monday, the Dow traded up 0.04% to 33,901.46 while the NASDAQ fell 0.09% to 12,112.19....
Via
Benzinga
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
↗
April 17, 2023
Merck is branching into immune-mediated diseases with this takeover.
Via
Investor's Business Daily
PRST Stock Alert: What to Know About Red-Hot Presto Automation Today
↗
April 17, 2023
Presto Automation (PRST) stock is seeing massive gains with heavy trading on Monday despite a lack of news from the AI company.
Via
InvestorPlace
Why Is NIO Stock Up Today?
↗
April 17, 2023
Nio (NIO) stock is climbing higher on Monday after the EV company announced the launch of its new power charging stations.
Via
InvestorPlace
RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today
↗
April 17, 2023
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today.
Via
InvestorPlace
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
↗
April 17, 2023
SAI.TECH Global (SAI) stock is down on Monday despite a lack of news concerning the Bitcoin (BTC-USD) mining and clean energy company.
Via
InvestorPlace
Why Is Marpai (MRAI) Stock Down 40% Today?
↗
April 17, 2023
Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 17, 2023
Via
Benzinga
XPeng Is Charging Higher, but This Biotech Stock Is Monday's Biggest Winner
↗
April 17, 2023
Markets are watching corporate earnings very carefully.
Via
The Motley Fool
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
↗
April 17, 2023
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).
Via
InvestorPlace
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
↗
April 17, 2023
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.
Via
Benzinga
Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline
↗
April 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
April 17, 2023
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Nasdaq, S&P 500 Futures Muted; Analyst Says Don't Expect Good News This Earnings Season
↗
April 17, 2023
Early indications suggest that stocks could start the week on a tentative note, which was characteristic of trading during most of last week. Traders may show restraint as they look ahead to...
Via
Benzinga
Prometheus Biosciences, XPeng And Other Big Stocks Moving Higher In Monday's Pre-Market Session
↗
April 17, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 70.1% to $193.93...
Via
Benzinga
RXDX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Prometheus Biosciences, Inc. is Fair to Shareholders
April 16, 2023
From
Halper Sadeh LLC
Via
Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
April 16, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
↗
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 09, 2023
From
Prometheus Biosciences
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
